Tech Company Financing Transactions

Enigma Biomedical USA Funding Round

The Michael J. Fox Foundation for Parkinson's Research participated in a $2 million funding round for Enigma Biomedical USA. The round was announced by the company on 11/25/2025.

Transaction Overview

Announced On
11/25/2025
Transaction Type
Debt
Amount
$2,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
308 N. Peters Road 201
Knoxville, TN 37922
USA
Phone
Undisclosed
Email Address
Overview
Our Vision is to be the premier provider of information and technology to researchers and clinicians in order to improve brain health. Our Mission: To provide broad access to biomarkers of neurological pathologies, essential enabling tools and information technology to accelerate the development and approval of effective therapies to treat Alzheimer's and other neurodegenerative diseases.
Profile
Enigma Biomedical USA LinkedIn Company Profile
Social Media
Enigma Biomedical USA Company Twitter Account
Company News
Enigma Biomedical USA News
Facebook
Enigma Biomedical USA on Facebook
YouTube
Enigma Biomedical USA on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rick Hiatt
  Rick Hiatt LinkedIn Profile  Rick Hiatt Twitter Account  Rick Hiatt News  Rick Hiatt on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/25/2025: Range venture capital transaction
Next: 11/25/2025: Mira venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document funding rounds that are announced publicly. All VC database entries on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary